文献速递脑血管病

抑郁遗传风险与缺血性卒中后功能结局的孟德尔随机化研究

Genetically Determined Risk of Depression and Functional Outcome After Ischemic Stroke.
PubMed 文献 · Stroke · 2019-06-26

本研究利用孟德尔随机化框架,探讨遗传决定的抑郁风险对缺血性卒中风险及3个月功能结局的影响。结果显示遗传决定的抑郁风险对缺血性卒中风险无显著影响,但主要分析提示对功能结局可能有不良影响(OR 1.81, 95%CI 0.98-3.35, P=0.06),加权中位数法支持该关联(OR 2.57, 95%CI 1.05-6.25, P=0.04)。

要点

  • 遗传决定的抑郁风险与缺血性卒中风险无显著因果关联。
  • 遗传决定的抑郁风险可能增加缺血性卒中后3个月功能不良结局的风险。
  • 该关联需更大样本验证,但提示抑郁遗传风险或可用于卒中后预后评估。

核心结论

  • 未发现遗传决定的抑郁风险影响缺血性卒中风险的孟德尔随机化证据。
  • 发现一致的孟德尔随机化证据提示遗传决定的抑郁风险可能影响缺血性卒中后功能结局。

研究设计与样本

  • 卒中后3个月功能结局的遗传关联估计来自6021例患者的分析。

主要发现

  • 遗传决定的抑郁风险对缺血性卒中风险无孟德尔随机化证据。
  • 主要逆方差加权孟德尔随机化分析提示遗传决定的抑郁风险对卒中后功能结局有不良影响(每增加1个标准差,不良结局[改良Rankin量表≥3]的比值比1.81;95%CI 0.98-3.35;P=0.06)。
  • 不同工具产生的孟德尔随机化估计无异质性(Q P=0.26)。
  • 加权中位数孟德尔随机化得到可比估计(比值比2.57;95%CI 1.05-6.25;P=0.04)。
  • MR-PRESSO得到可比估计(比值比1.81;95%CI 0.95-3.46;P=0.08)。

关键数值与推荐

  • 功能结局不良定义为改良Rankin量表评分≥3。
  • 主要分析统计效力较低,但结果提示遗传决定的抑郁风险对功能结局可能有不良影响。

临床怎么用

  • 抑郁相关疾病患病率广泛,这些发现可能对卒中后预后判断和个性化康复有启示。

局限性

  • 主要逆方差加权孟德尔随机化分析统计效力较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Psychosocial factors can have implications for ischemic stroke risk and recovery. This study investigated the effect of genetically determined risk of depression on these outcomes using the Mendelian randomization (MR) framework. Methods- Genetic instruments for risk of depression were identified in a discovery genome-wide association study of 246 363 cases and 561 190 controls and further replicated in a separate population of 474 574 cases and 1 032 579 controls. Corresponding genetic association estimates for risk of ischemic stroke were taken from 60 341 cases and 454 450 controls, with those for functional outcome 3 months after ischemic stroke taken from an analysis of 6021 patients. Following statistical power calculation, inverse-variance weighted MR was performed to pool estimates across different instruments. The Cochran Q heterogeneity test, weighted median MR, and MR pleiotropy residual sum and outlier were used to explore possible bias relating to inclusion of pleiotropic variants. Results- There was no MR evidence for an effect of genetically determined risk of depression on ischemic stroke risk. Although suffering low statistical power, the main inverse-variance weighted MR analysis was suggestive of a detrimental effect of genetically determined risk of depression on functional outcome after ischemic stroke (odds ratio of poor outcome [modified Rankin Scale, ≥3] per 1-SD increase in genetically determined risk of depression, 1.81; 95% CI, 0.98-3.35; P=0.06). There was no evidence of heterogeneity between MR estimates produced by different instruments (Q P=0.26). Comparable MR estimates were obtained with weighted median MR (odds ratio, 2.57; 95% CI, 1.05-6.25; P=0.04) and MR pleiotropy residual sum and outlier (odds ratio, 1.81; 95% CI, 0.95-3.46; P=0.08). Conclusions- We found no MR evidence of genetically determined risk of depression affecting ischemic stroke risk but did find consistent MR evidence suggestive of a possible effect on functional outcome after ischemic stroke. Given the widespread prevalence of depression-related morbidity, these findings could have implications for prognostication and personalized rehabilitation after stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gill D, James NE, Monori G, et al. Genetically Determined Risk of Depression and Functional Outcome After Ischemic Stroke. Stroke. 2019. PMID: 31238828. doi:10.1161/STROKEAHA.119.026089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。